![Christine Silverstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christine Silverstein
Direktor/Vorstandsmitglied bei
ABEONA THERAPEUTICS INC.
Vermögen: 691 068 $ am 31.05.2026
Profil
Christine Berni Silverstein currently works at Abeona Therapeutics, Inc., as Independent Director from 2020, National Investor Relations Institute, as Member, Women in Bio, Inc., as Member, Project 1972, Inc., as Member, and Artios Pharma Ltd., as Chief Financial Officer from 2024.
Ms. Silverstein also formerly worked at SCO Financial Group LLC, as Managing Director, Relmada Therapeutics, Inc., as Director-Investor Relations from 2014 to 2016, Marinus Pharmaceuticals, Inc., as Independent Director from 2023 to 2025, Excision BioTherapeutics, Inc., as Chief Financial Officer from 2021 to 2024, and Emendo Biotherapeutics, Inc., as Chief Financial Officer from 2020 to 2021.
Ms. Silverstein received her undergraduate degree from Peter J.
Tobin College of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 119’562 ( 0.21% ) | 691 068 $ | 31.05.2026 |
Aktive Positionen von Christine Silverstein
| Unternehmen | Position | Beginn |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 11.03.2020 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
Women in Bio, Inc.
 Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization to help women entrepreneurs and executives | Corporate Officer/Principal | - |
Project 1972, Inc.
 Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a women’s leadership network that promotes members to amplify their influence, access tools and connections | Corporate Officer/Principal | - |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Finanzdirektor/CFO | 01.02.2024 |
Ehemalige bekannte Positionen von Christine Silverstein
| Unternehmen | Position | Ende |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 11.02.2025 |
Excision BioTherapeutics, Inc.
 Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Finanzdirektor/CFO | 01.01.2024 |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Finanzdirektor/CFO | 01.01.2021 |
| RELMADA THERAPEUTICS, INC. | Investor Relations Kontakt | 01.01.2016 |
| ░░░ ░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Christine Silverstein
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
SCO Financial Group LLC
 SCO Financial Group LLC Investment Banks/BrokersFinance Operates a full service merchant bank | Finance |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Women in Bio, Inc.
Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization to help women entrepreneurs and executives | Commercial Services |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Peter J. Tobin College of Business
 Peter J. Tobin College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
Excision BioTherapeutics, Inc.
Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Health Technology |
Project 1972, Inc.
Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a women’s leadership network that promotes members to amplify their influence, access tools and connections | Commercial Services |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
